"All that palsies is not Bell's [1]"-The need to define Bell's palsy as an adverse event following immunization

Vaccine

Volumn 26, Issue 1, 2007, Pages 1-14

  Rath, Barbara ^a   Linder, Thomas ^b   Cornblath, David ^c   Hudson, Michael ^d   Fernandopulle, Rohini ^e   Hartmann, Katharina ^f   Heininger, Ulrich ^a   Izurieta, Hector ^g   Killion, Leslie ^h   Kokotis, Pangiotis ⁱ   Oleske, James ^j   Vajdy, Michael ^k   Wong, Virginia ^l  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Kantonsspital Luzern ^*  (Switzerland)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^f Berna Biotech AG   (Switzerland)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h PFIZER INC   (United States)

ⁱ NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^j RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^k Novartis Vaccines and Diagnostics Inc   (United States)

^l UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

AEFI; Bell's palsy; Clinical definition

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; LYME DISEASE VACCINE; MEASELES MUMPS RUBELLA VACCINE; MENINGITIS VACCINE; NASALFLU VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; SMALLPOX VACCINE; SWISS INFLUENZA VACCINE; UNCLASSIFIED DRUG; VACCINE;

BELL PALSY; CHRONOLOGY; CLINICAL TRIAL; DATA BASE; DIAGNOSTIC PROCEDURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG INDUCED HEADACHE; ELECTRODIAGNOSIS; FACIAL NERVE; FACIAL NERVE PARALYSIS; FEVER; HUMAN; IMMUNIZATION; INFLUENZA; MEDICAL LITERATURE; NEUROIMAGING; PEDIATRICS; PRIORITY JOURNAL; RATING SCALE; REVIEW; RHINORRHEA; SIDE EFFECT; SNEEZING; STUFFY NOSE; VIROLOGY;

ACTION POTENTIALS; BELL PALSY; CHILD; HUMANS; IMMUNIZATION; MAGNETIC RESONANCE IMAGING;

EID: 36749085269     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.043     Document Type: Review

References (229)

1. May M., and Schaitkin B.M. History of facial nerve surgery. Facial Plast Surg 16 (2000) 301-307
2. Zurbriggen R., Metcalfe I.C., Gluck R., Viret J.F., and Moser C. Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine. Exp Rev Vac 2 2 (2003) 295-304 [Review] [34 refs.]
3. Harandi A.M., Sanchez J., Eriksson K., and Holmgren J. Recent developments in mucosal immunomodulatory adjuvants. Curr Opin Investig Drugs 4 2 (2003) 156-161
4. Sendi P., Locher R., Bucheli B., and Battegay M. Intranasal influenza vaccine in a working population. Clin Infect Dis 38 7 (2004) 974-980
5. Genton B., D'Acremont V., Sendi P., Locher R., and Battegay M. Intranasal versus injectable influenza vaccine [1] (multiple letters). Clin Infect Dis 39 5 (2004) 754-755
6. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. NEJM 350 9 (2004) 896-903
7. Glueck R. Review of intranasal influenza vaccine. Adv Drug Deliv Rev 51 1-3 (2001) 203-211
8. Gluck U., Gebbers J.O., and Gluck R. Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers. J Virol 73 9 (1999) 7780-7786
9. Gluck R., Mischler R., Durrer P., Furer E., Lang A.B., Herzog C., et al. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant. J Infect Dis 181 3 (2000) 1129-1132
10. NIAID. Safety Evaluation of Toxin Adjuvants Delivered Intranasally. In: NIAID report on meeting evaluating safety of IN vaccine adjuvants 2001.
11. Po A.L.W. Non-parenteral vaccines. Br Med J 329 7457 (2004) 62-63
12. Swiss nasal flu vaccine linked to Bell's palsy. Harvard Health Lett 29 7 (2004) 7
13. Battegay M., Locher R., Bucheli B., and Sendi P. Effectiveness, safety and desirability of a nasal influenza vaccine. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL (2003) [abstract no G-883]
14. Fox S. Swiss intranasal flu vaccine linked to Bell palsy. Infect Med 21 4 (2004) 151
15. Borchers A.T., Keen C.L., Shoenfeld Y., Silva Jr. J., and Gershwin M.E. Vaccines, viruses, and voodoo. J Investig Allerg Clin Immunol 12 3 (2002) 155-168
16. Couch R.B. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy [comment]. New Engl J Med 350 9 (2004) 860-861
17. Lycke N. Targeted vaccine adjuvants based on modified cholera toxin. Curr Mol Med 5 6 (2005) 591-597
18. Izurieta H.S., Haber P., Wise R.P., Iskander J., Pratt D., Mink C., et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 294 21 (2005) 2720-2725
19. Zhou W., Pool V., DeStefano F., Iskander J.K., Haber P., and Chen R.T. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Pharmacoepidemiol Drug Saf 13 8 (2004) 505-510
20. Shapiro S. Clinical judgment, common sense and adverse reaction reporting. Pharmacoepidemiol Drug Saf 13 8 (2004) 511-513
21. Mann R.D. Assessments of disproportionality. Pharmacoepidemiol Drug Saf 13 8 (2004) 501-502
22. Chou C.H., Liou W.P., Hu K.I., Loh C.H., Chou C.C., and Chen Y.H. Bell's palsy associated with influenza vaccination: two case reports. Vaccine 19 (2006) 19
23. Stowe J., Andrews N., Wise L., and Miller E. Bell's palsy and parenteral inactivated influenza vaccine. Hum Vac 2 3 (2006) 110-112
24. Song B.J., and Katial R.K. Update on side effects from common vaccines. Curr Allerg Asthma Rep 4 6 (2004) 447-453
25. Vital C., Vital A., Gbikpi-Benissan G., Longy-Boursier M., Climas M.T., Castaing Y., et al. Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases. J Peripheral Nerv Syst 7 3 (2002) 163-167
26. Sejvar J.J., Labutta R.J., Chapman L.E., Grabenstein J.D., Iskander J., and Lane J.M. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 294 21 (2005) 2744-2750
27. Gilden D.H. Clinical practice. Bell's Palsy. N Engl J Med 351 13 (2004) 1323-1331
28. van de Graaf R.C., and Nicolai J.P. Bell's palsy before Bell: Cornelis Stalpart van der Wiel's observation of Bell's palsy in 1683. Otol Neurotol 26 6 (2005) 1235-1238
29. Pearce J.M. Bell's or Friedreich's palsy. J Neurol Neurosurg Psychiatry 67 6 (1999) 732
30. Taverner D. Cortisone treatment of Bell's palsy. Lancet 2 (1954) 1052-1054
31. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549 (2002) 4-30
32. Singhi P., and Jain V. Bell's palsy in children. Semin Pediatr Neurol 10 4 (2003) 289-297
33. Benatar M., and Edlow J. The spectrum of cranial neuropathy in patients with Bell's palsy. Arch Intern Med 164 21 (2004) 2383-2385
34. Valença M.M., de Andrade Valença L.P.A., and Lima M.C.M. Paralisia Facial periferica idiopatica de Bell. A propósito de 180 pacientes. Arq Neuropsiquiatr 59 3-B (2001) 733-739
35. Kaygusuz I., Godekmerdan A., Keles E., Karlidag T., Yalcin S., Yildiz M., et al. The role of viruses in idiopathic peripheral facial palsy and cellular immune response. Am J Otolaryngol 25 6 (2004) 401-406
36. Ramsey M.J., DerSimonian R., Holtel M.R., and Burgess L.P. Corticosteroid treatment for idiopathic facial nerve paralysis: a meta-analysis. Laryngoscope 110 3 Pt 1 (2000) 335-341
37. Vanopdenbosch L.J., Verhoeven K., and Casselman J.W. Bell's palsy with ipsilateral numbness. J Neurol Neurosurg Psychiatry (2005)
38. Watanabe T., and Suzuki M. Equilibrium test findings in patients with Bell's palsy. Auris Nasus Larynx 33 2 (2006) 143-147
39. Ogita S., Terada K., Niizuma T., Kosaka Y., and Kataoka N. Characteristics of facial nerve palsy during childhood in Japan: frequency of varicella-zoster virus association. Pediatr Int 48 3 (2006) 245-249
40. Linder T., Bossart W., and Bodmer D. Bell's palsy and Herpes simplex virus: fact or mystery?. Otol Neurotol 26 1 (2005) 109-113
41. Chen W.X., and Wong V. Prognosis of Bell's palsy in children-analysis of 29 cases. Brain Dev 27 7 (2005) 504-508
42. Furuta Y., Ohtani F., Chida E., Mesuda Y., Fukuda S., and Inuyama Y. Herpes simplex virus type 1 reactivation and antiviral therapy in patients with acute peripheral facial palsy. Auris Nasus Larynx 28 (2001) S13-S17
43. Robillard R.B., Hilsinger Jr. R.L., and Adour K.K. Ramsay Hunt facial paralysis: clinical analyses of 185 patients. Otolaryngol Head Neck Surg 95 3 Pt 1 (1986) 292-297
44. Gilbert S.C. Bell's palsy and herpesviruses. Herpes 9 3 (2002) 70-73
45. De Diego J.I., Prim M.P., Madero R., and Gavilan J. Seasonal patterns of idiopathic facial paralysis: a 16-year study. Otolaryngol Head Neck Surg 120 2 (2002) 269-271
46. Qiu W.W., Yin S.S., Stucker F.J., Aarstad R.F., and Nguyen H.H. Time course of Bell palsy. Arch Otolaryngol Head Neck Surg 122 9 (1996) 967-972
47. Holland N.J., and Weiner G.M. Recent developments in Bell's palsy. Br Med J 329 (2004) 553-557
48. Ahmed A. When is facial paralysis Bell palsy? Current diagnosis and treatment. Cleve Clin J Med 72 5 (2005) 398-401 405
49. Yanagihara N. Edematous swelling of the facial nerve in Bell's palsy. Acta Oto-Laryngol 120 5 (2000) 667-671
50. El-Ebiary H.M. Facial paralysis. A clinical Study of 580 cases. Rheumatology 11 3 (1971) 100
51. Piercy J. Bell's palsy. BMJ 330 7504 (2005) 1374
52. Adour K.K., Byl F.M., Hilsinger Jr. R.L., Kahn Z.M., and Sheldon M.I. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope 88 5 (1978) 787-801
53. Shafshak T.F. The treatment of facial palsy from the point of view of physical and rehabilitation medicine. Eura Medicophys 42 1 (2006) 41-47
54. Shafshak T.S., Essa A.Y., and Bakey F.A. The possible contributing factors for the success of steroid therapy in Bell's palsy: a clinical and electrophysiological study. J Laryngol Otol 108 11 (1994) 940-943
55. Linder T.E., Bodmer D., Sartoretti S., Felix H., and Bossart W. Bell's palsy: still a mystery?. Otol Neurotol 23 1 (2002) S15
56. Vasconcelos B.C., Bessa-Nogueira R.V., Maurette P.E., and Carneiro S.C. Facial nerve paralysis after impacted lower third molar surgery: a literature review and case report. Med Oral Patol Oral Cir Bucal 11 2 (2006) E175-E178
57. House J.W. Facial nerve grading systems. Laryngoscope 93 8 (1983) 1056-1069
58. Berg T., Jonsson L., and Engstrom M. Agreement between the Sunnybrook, House-Brackmann, and Yanagihara facial nerve grading systems in Bell's palsy. Otol Neurotol 25 6 (2004) 1020-1026
59. Croxson G., May M., and Mester S.J. Grading facial nerve function: House-Brackmann versus Burres-Fisch methods. Am J Otol 11 4 (1990) 240-246
60. Neely J.G., Joaquin A.H., Kohn L.A., and Cheung J.Y. Quantitative assessment of the variation within grades of facial paralysis. Laryngoscope 106 4 (1996) 438-442
61. Yen T.L., Driscoll C.L., and Lalwani A.K. Significance of House-Brackmann facial nerve grading global score in the setting of differential facial nerve function. Otol Neurotol 24 1 (2003) 118-122
62. Coulson S.E., Croxson G.R., Adams R.D., and O'Dwyer N.J. Reliability of the "Sydney," "Sunnybrook," and "House Brackmann" facial grading systems to assess voluntary movement and synkinesis after facial nerve paralysis. Otolaryngol Head Neck Surg 132 4 (2005) 543-549
63. Kang T.S., Vrabec J.T., Giddings N., and Terris D.J. Facial nerve grading systems (1985-2002): beyond the House-Brackmann scale. Otol Neurotol 23 5 (2002) 767-771
64. Alaani A., Hogg R., Saravanappa N., and Irving R.M. An analysis of diagnostic delay in unilateral facial paralysis. J Laryngol Otol 119 3 (2005) 184-188
65. Gillman G.S., Schaitkin B.M., May M., and Klein S.R. Bell's palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 126 1 (2002) 26-30
66. Grogan P.M., and Gronseth G.S. Practice parameter: steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 7 (2001) 830-836
67. Kokotis P., Piperos P., Zambelis T., and Karandreas N. Denervation pattern of three mimic muscles in Bell's palsy. Neurophysiol Clin 36 4 (2006) 255-259
68. Lagalla G., Logullo F., Di Bella P., Provinciali L., and Ceravolo M.G. Influence of early high-dose steroid treatment on Bell's palsy evolution. Neurol Sci 23 3 (2002) 107-112
69. Lazarini P.R., Vianna M.F., Alcantara M.P.A., Scalia R.A., and Caiaffa Filho H.H. Herpes simplex virus in the saliva of peripheral Bells palsy patients. Rev Brasil Otorrinolaringol 72 (2006) 7-11
70. Unuvar E., Oguz F., Sidal M., and Kilic A. Corticosteroid treatment of childhood Bell's palsy. Pediatr Neurol 21 5 (1999) 814-816
71. Salinas R.A., Alvarez G., Alvarez M.I., and Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis) (Cochrane Review). Cochrane Library (2002) 2
72. Rickenmann J., Jaquenod C., Cerenko D., and Fisch U. Comparative value of facial nerve grading systems. Otolaryngol Head Neck Surg 117 4 (1997) 322-325
73. Adour K.K. Cranial polyneuritis and Bell palsy. Arch Otolaryngol Head Neck Surg 102 5 (1976) 262-264
74. Gilden D.H., Cohrs R.J., Hayward A.R., Wellish M., and Mahalingam R. Chronic varicella-zoster virus ganglionitis-a possible cause of postherpetic neuralgia. J Neurovirol 9 3 (2003) 404-407
75. Sweeney C.J., and Gilden D.H. Ramsay Hunt syndrome. BMJ (2001)
76. Berman S. Otitis media in developing countries. Pediatrics 96 1 Pt 1 (1995) 126-131
77. Marson A.G., and Salinas R. Bell's palsy. West J Med 173 4 (2000) 266-268
78. Ashtekar C.S., Joishy M., and Joshi R. Do we need to give steroids in children with Bell's palsy?. BAEM (2005)
79. Shmorgun D., Chan W.S., and Ray J.G. Association between Bell's palsy in pregnancy and pre-eclampsia. QJM 95 6 (2002) 359-362
80. Hilsinger Jr. R.L., Adour K.K., and Doty H.E. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 84 4 (1975) 433-442
81. Philippin O., Dobbie M., and Reusser P. Bell's palsy: idiopathic or infectious?. Revue Medicale de la Suisse Romande 122 (2002) 81-83 [in French]
82. Stjernquist-Desatnik A., Skoog E., and Aurelius E. Detection of herpes simplex and varicella-zoster viruses in patients with Bell's palsy by the polymerase chain reaction technique. Ann Otol Rhinol Laryngol 115 4 (2006) 306-311
83. Shao P.L., Lu C.Y., Chang L.Y., Huang F.Y., Wang C.Y., Yang C.Y., et al. Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in Taiwanese infants. J Formosan Med Assoc 103 8 (2004) 613-617
84. Roob G., Fazekas F., and Hartung H.P. Peripheral facial palsy: etiology, diagnosis and treatment. Eur Neurol 41 1 (1999) 3-9
85. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol Head Neck Surg 107 1 (1981) 1-11
86. Galli M., Lisa A.M., Formenti A., Negri-Chinaglia C., Zara C., Del Giudice G., et al. Humoral immunity profile in idiopathic paralysis of the VIIth cranial nerve. Acta Otorhinolaryngol Ital 3 4 (1983) 409-415 [in Italian]
87. Gandhi A., and Wilson D.G. Incomplete Kawasaki disease: not to be forgotten [3]. Arch Dis Childhood 91 3 (2006) 276-277
88. Halperin J.J., Golightly M., and Long Island Neuroborreliosis Collaborative Study Group. Lyme borreliosis in Bell's palsy. Neurology 42 7 (1992) 1268-1270
89. Greene R.M., and Rogers III R.S. Melkersson-Rosenthal syndrome: a review of 36 patients. J Am Acad Dermatol 21 6 (1989) 1263-1270
90. Baraitser M. Genetics of Mobius syndrome. J Med Genet 14 6 (1977) 415-417
91. Giannotti A., Digilio M.C., Marino B., Mingarelli R., and Dallapiccola B. Cayler cardiofacial syndrome and del 22q11: part of the CATCH22 phenotype. Am J Med Genet 53 3 (1994) 303-304
92. McCormick. Herpes simplex virus as a cause of Bell's palsy. Lancet 1 (1972) 937-939
93. McCormick D.P., and Spruance R.S.L. Herpes simplex virus as a cause of Bell's palsy. Rev Med Virol 10 5 (2000) 285-289
94. Dumitru D., Walsh N.E., and Porter L.D. Electrophysiologic evaluation of the facial nerve in Bell's palsy. A review. Am J Phys Med Rehabil 67 4 (1988) 137-144
95. Rossi G., and Solero P. Electroneuronography in the diagnosis and prognosis of diseases of the facial nerve. Acta Otolaryngol 89 34 (1980) 271-276
96. Tojima H., Aoyagi M., Inamura H., and Koike Y. Clinical advantages of electroneurography in patients with Bell's palsy within two weeks after onset. Acta Otolaryngol Suppl 511 (1994) 147-149
97. Furuta Y., Ohtani F., Kawabata H., Fukuda S., and Bergstroem T. High prevalence of Varicella-Zoster Virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy. Clin Infect Dis 30 3 (2000) 529-533
98. Esslen E. The acute facial palsies: investigations on the localization and pathogenesis of meato-labyrinthine facial palsies. Schriftenr Neurol 18 (1977) 1-164
99. Yasukawa M., Yasukawa K., and Ohnuma H. Prognostic diagnosis of facial palsy with electroneuronography. Masui 44 3 (1995) 378-387
100. Ghonim M.R., and Gavilan C. Blink reflex: prognostic value in acute peripheral facial palsy. ORL J Otorhinolaryngol Relat Spec 52 2 (1990) 75-79
101. Brandle P., Satoretti-Schefer S., Bohmer A., Wichmann W., and Fisch U. Correlation of MRI, clinical, and electroneuronographic findings in acute facial nerve palsy. Am J Otol 17 1 (1996) 154-161
102. Charcot J.M. Lessons learnt on nervous system diseases at La Salpetiere, Volume III [Lecons sur les maladies du systeme nerveux faites a la Salpetriere, Tome III] (1887), A Delahaye & E Lecrosnie, Paris [in French]
103. Boongird P., and Vejjajiva A. Electrophysiologic findings and prognosis in Bell's palsy. Muscle Nerve 1 6 (1978) 461-466
104. Kokotis P., Piperos P., and Karandreas N. Differential presence of fibrillation in mimic muscles in Bell's palsy. Electromyogr Clin Neurophysiol 44 7 (2004) 395-399
105. Thomander L., and Stalberg E. Electroneurography in the prognostication of Bell's palsy. Acta Otolaryngol 92 3-4 (1981) 221-237
106. Fisch U. Prognostic value of electrical tests in acute facial paralysis. Am J Otol 5 6 (1984) 494-498
107. Celik M., and Forta H. Electrophysiological investigations and prognosis in idiopathic facial palsy. Electromyogr Clin Neurophysiol 37 5 (1997) 311-315
108. Gavilan C., Gavilan J., Rashad M., and Gavilan M. Discriminant analysis in predicting prognosis of Bell's palsy. Acta Otolaryngol 106 3-4 (1988) 276-280
109. He L., Zhou D., Wu B., Li N., and Zhou M.K. Acupuncture for Bell's palsy. Cochrane Database of Systematic Reviews 2004 1 (2004)
110. Gantz B.J., Rubinstein J.T., Gidley P., and Woodworth G.G. Surgical management of Bell's palsy. Laryngoscope 109 8 (1999) 1177-1188
111. Giudice E.L., and Campbell J.D. Needle-free vaccine delivery. Adv Drug Deliv Rev 58 1 (2006) 68-89
112. Bakke H., Samdal H.H., Holst J., Oftung F., Haugen I.L., Kristoffersen A.C., et al. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity. Scand J Immunol 63 3 (2006) 223-231
113. Dean H.J. Alternative routes of influenza vaccine delivery. Expert Opin Drug Deliv 3 5 (2006) 557-561
114. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 293 1 (2003) 3-15
115. Gibson A. Pain-free immunization-The future of vaccine delivery. Eur Pharm Contract (2002) 58-63. http://www.samedanltd.com/magazine/11/issue/21/article/1070 URL: http://www.samedanltd.com/magazine/11/issue/21/article/1070, Accessed: May 5, 2007
116. Vajdy M., and Singh M. Intranasal delivery of vaccines against HIV. Expert Opin Drug Deliv 3 2 (2006) 247-259
117. Tamura S.I., and Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis 57 6 (2004) 236-247
118. Tamura S.I., Tanimoto T., and Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J Infect Dis 58 4 (2005) 195-207
119. Deen J.L., and Clemens J.D. Issues in the design and implementation of vaccine trials in less developed countries. Nat Rev Drug Discov 5 (2006) 932-940
120. Girard M.P., Cherian T., Pervikov Y., and Kieny M.P. A review of vaccine research and development: human acute respiratory infections. Vaccine 23 50 (2005) 5708-5724
121. Glenn G.M., Kenney R.T., Hammond S.A., and Ellingsworth L.R. Transcutaneous immunization and immunostimulant strategies. Immunol Allergy Clin North Am 23 4 (2003) 787-813
122. Folb P.I., Bernatowska E., Chen R., Clemens J., Dodoo A.N.O., Ellenberg S.S., et al. A global perspective on vaccine safety and public health: The Global Advisory Committee on Vaccine Safety. Am J Public Health 94 11 (2004) 1926-1931
123. Global Advisory Committee on Vaccine Safety (GAVS). Wkly Epidemiol Rec 77 June (47) (2002) 389-394
124. Cassetti M.C., Couch R., Wood J., and Pervikov Y. Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004. Vaccine 23 13 (2005) 1529-1533
125. Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults. A randomized controlled trial. JAMA 282 2 (1999) 137-144
126. Wong S.S.Y., and Yuen K.Y. Influenza vaccination: options and issues. Hong Kong Med J 11 5 (2005) 381-390
127. Possible neurological side effects of hepatitis B vaccination. Prescrire Int 6 28 (1997) 57-58
128. Don't exaggerate the systemic adverse effects of hepatitis B vaccination. The vaccine benefits people at risk. Prescrire Int 9 46 (2000) 59-63
129. Ganry O., Lerailler F., Vercelletto M., Chiffoleau A., and Larousse C. Peripheral facial paralysis following vaccination against hepatitis B. Apropos of a case. Therapie 47 5 (1992) 437-438 [in French]
130. Lacour J.P. Hepatitis, vaccine, multiple sclerosis and lichen: the moral of the story. Ann Dermatol Venereol 125 6-7 (1998) 395-397
131. Shaw Jr. F.E., Graham D.J., Guess H.A., Milstien J.B., Johnson J.M., Schatz G.C., et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol 127 2 (1988) 337-352 [Review] [45 refs]
132. Boe E., and Nyland H. Guillain-Barre syndrome after vaccination with human diploid cell rabies vaccine. Scand J Infect Dis 12 3 (1980) 231-232
133. Consoloni E., Cartei M.A., Ioppoli C., and Fonte F. Neuropathological complications of rabies vaccination: a case with involvement of the facial nerve. Riv Neurol 49 1 (1979) 53-61 [in Italian]
134. Cremieux G., Dor J.F., and Mongin M. Peripheral facial paralysis and post-antirabies-vaccination polyneuroradiculitis. Acta Neurol Belg (1978) 279-300 [in French]
135. Cremieux G., et al. Facial diplegia with cellular albumin dissociation of the cerebrospinal fluid following rabies vaccination. Nouvelle Presse Medicale 6 31 (1977) 2781-2782 [in French]
136. Kuwert E., Klosterkotter W., and Linzenmeier G. Neurological complications following rabies vaccination. Med Klin 63 34 (1968) 1326-1328 [in German]
137. Srivastava A.K., Sardana V., Prasad K., and Behari M. Diagnostic dilemma in flaccid paralysis following anti-rabies vaccine. Neurol India 52 1 (2004) 132-133
138. Verma A., and Maheshwari M.C. Facial diplegia following antirabies vaccine. J Assoc Phys India 34 8 (1986) 603-604
139. Bodechtel G., Haas R., Joppich G., Lennartz H., and Siegert R. Vaccination complications after oral poliomyelitis vaccination (author's transl.). MMW-Munchener Medizinische Wochenschrift 119 16 (1977) 521-528 [in German]
140. Friedrich F. Rare adverse events associated with oral poliovirus vaccine in Brazil. Braz J Med Biol Res 30 (1997) 695-703
141. Friedrich F., Filippis A.M., Ferreira F.C., Schatzmayr H.G., and Da Silva E.E. Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil. Acta Virol 39 1 (1995) 23-29
142. Marzetti G., Bertolini L., and Midulla M. Virological and clinical study of morbid manifestations connected with anti-poliomyelitis vaccination with the oral Sabin vaccine. Minerva Pediatrica 19 50 (1967) 2236-2245 [in Italian]
143. Neogi S.B. Polio declining but AFP on the rise. Indian Pediatr 43 2 (2006) 185-186
144. Hsia E.C., Chung J.B., Schwartz J.S., and Albert DA. Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis rheum 46 6 (2002) 1651-1660
145. Lathrop S.L., Ball R., Haber P., Mootrey G.T., Braun M.M., Shadomy S.V., et al. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine 20 11-12 (2002) 1603-1608
146. Oransky I., and Saraiya A. The Lyme disease vaccine: Implications for Bell palsy. Infect Med 17 6 (2000) 456-457
147. Katafuchi Y., Aida K., Shiotsuki Y., Yamashita Y., Horikawa M., and Andou H. Acute cerebellar ataxia and facial palsy after DPT immunization. No to Hattatsu [Brain Dev] 21 5 (1989) 465-469 [in Japanese]
148. Martin G.I., and Weintraub M.I. Brachial neuritis and seventh nerve palsy-a rare hazard of DPT vaccination. Clin Pediatr 12 8 (1973) 506-507
149. Kuno-Sakai H., and Kimura M. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization. Pediatr Int 46 6 (2004) 650-655
150. Laribiere A., Miremont-Salame G., Reyre H., Abouelfath A., Liege L., Moore N., et al. Surveillance of adverse effects during a vaccination campaign against meningitis C. Eur J Clin Pharmacol 61 12 (2005) 907-911
151. McCormick A., Dinakaran S., Bhola R., and Rennie I.G. Recurrent sixth nerve palsy following measles mumps rubella vaccination [18]. Eye 15 3 (2001) 356-357
152. Snyder R.D. Facial palsy following measles vaccination, a possible connection. Pediatrics 42 1 (1968) 215-216
153. Wairagkar N.S., Gandhi B.V., Katrak S.M., Shaikh N.J., Parikh P.R., Wadia N.H., et al. Acute renal failure with neurological involvement in adults associated with measles virus isolation. Lancet 354 9183 (1999) 992-995
154. Talbot T.R., Stapleton J.T., Brady R.C., Winokur P.L., Bernstein D.I., Germanson T., et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 292 10 (2004) 1205-1212
155. Neff J.M., Levine R.H., Lane J.M., Ager E.A., Moore H., Rosenstein B.J., et al. Complications of smallpox vaccination United States 1963. II: Results obtained by four statewide surveys. Pediatrics 39 6 (1967) 916-923
156. Polack M. Complications of smallpox vaccination in the Netherlands, 1959-1970. In: Standard S.S.I. (Ed). International Symposium on Smallpox Vaccine 1972 (1972), Bilthoven, Netherlands 235-242
157. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl. 2 (2003) S89-S95
158. Kemble G., and Greenberg H. Novel generations of influenza vaccines. Vaccine 21 16 (2003) 1789-1795
159. Kersten G., and Hirschberg H. Antigen delivery systems. Exp Rev Vac 3 4 (2004) 453-462
160. Lycke N. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM. Cell Microbiol 6 1 (2004) 23-32
161. Mitragotri S. Immunization without needles. Nat Rev Immunol 5 12 (2005) 905-916
162. Peppoloni S., Ruggiero P., Contorni M., Morandi M., Pizza M., Rappuoli R., et al. Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. Exp Rev Vac 2 2 (2003) 285-293
163. Salzman M., Madsen J.M., and Greenberg M.I. Toxins: bacterial and marine toxins. Clin Lab Med 26 2 (2006) 397-419
164. Yanagihara N. Grading of facial palsy. Facial Nerve Surgery (1977), Aesculapius Publishing, Birmingham p. 533-6
165. Tomat L.R., and Manktelow R.T. Evaluation of a new measurement tool for facial paralysis reconstruction. Plast Reconstr Surg 115 (2005) 696
166. Dickins J.R., and Graham S.S. A comparison of facial nerve monitoring systems in cerebellopontine angle surgery. Am J Otol 12 1 (1991) 1-6
167. Engstrom M., Jonsson L., Grindlund M., and Stalberg E. Electroneurographic facial muscle pattern in Bell's palsy. Otolaryngol Head Neck Surg 122 2 (2000) 290-297
168. Figueroa J.P., Ashley D., King D., and Hull B. An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22. J Med Virol 29 4 (1989) 315-319
169. Lee F.S., Chu F.K., Tackley M., Wu A.D., Atri A., and Wessels M.R. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. Clin Infect Dis 31 5 (2000) 1288-1291
170. Arya S.C. Antiviral therapy for neurological manifestations of enterovirus 71 infection. Clin Infect Dis 30 6 (2000) 988
171. Wakisaka H., Hato N., Honda N., Takahashi H., Kisaki H., Murakami S., et al. Demyelination associated with HSV-1-induced facial paralysis. Exp Neurol 178 1 (2002) 68-79
172. Furuta Y., Fukuda S., Chida E., Takasu T., Ohtani F., Inuyama Y., et al. Reactivation of herpes simplex virus type 1 in patients with Bell's palsy. J Med Virol 54 3 (1998) 162-166
173. Belec L., Gherardi R., Georges A.J., Schuller E., Vuillecard E., Di Costanzo B., et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol 236 7 (1989) 411-414
174. Do P.H., and Bricaire F. Primary HIV infection, how to recognize it?. Schweiz Rundsch Med Prax 89 3 (2000) 70-78 [in French]
175. Berger J.R., Scott G., Albrecht J., Belman A.L., Tornatore C., and Major E.O. Progressive multifocal leukoencephalopathy in HIV-1-infected children. AIDS 6 8 (1992) 837-841
176. Baumgarten K.L., Lopez A.A., and Pankey G.A. Rash, bell's palsy, and back pain following a flu-like illness. Infect Med 16 6 (1999) 370-379
177. Ffytche T.J., and McDougall A.C. Leprosy and the eye: a review. J R Soc Med 78 5 (1985) 397-400
178. Gunatilake S.B., and Settinayake S. Leprosy. Pract Neurol 4 4 (2004) 194-203
179. Minagawa F., Yoshino Y., Abe M., Saito N., Ohsawa Y., Ozawa T., et al. Epidemiological immunological studies on leprosy in Okinawa. 6: Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients. Nippon Rai Gakkai Zasshi [Jpn J Leprosy] 58 2 (1989) 92-111 [in Japanese]
180. Evans J., and Schoen R.T. Lyme disease. Curr Opin Rheumatol 5 4 (1993) 454-460
181. Eppes S.C. Diagnosis, treatment, and prevention of Lyme disease in children. Paediatr Drugs 5 6 (2003) 363-372 [Review] [57 refs]
182. Nachman S.A., and Pontrelli L. Central nervous system Lyme disease. Semin Pediatr Infect Dis 14 2 (2003) 123-130
183. Nadelman R.B., Pavia C.S., Magnarelli L.A., and Wormser G.P. Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am J Med 88 1 (1990) 21-26
184. Nadelman R.B., and Wormser G.P. A clinical approach to Lyme disease. Mt Sinai J Med 57 (1990) 144-156
185. Shapiro E.D., and Gerber M.A. Lyme disease. Clin Infect Dis 31 2 (2000) 533-542
186. Steere A.C. Lyme disease. New Engl J Med 345 2 (2001) 115-125
187. Gurkan F., Bosnak M., Dikici B., Bosnak V., Yaramis A., Tas M.A., et al. Miliary tuberculosis in children: a clinical review. Scand J Infect Dis 30 4 (1998) 359-362
188. Spork E., Spork K.D., Millner M.M., Ranner G., Penka B., Popper H.H., et al. Pulmonary and central nervous system tuberculosis in an infant. Monatsschrift fur Kinderheilkunde 142 6 (1994) 406-408
189. Bechar M., Davidovich S., Goldhammer G., Machtey I., and Gadoth N. Neurological complications following rubella infection. J Neurol 226 4 (1982) 283-287
190. De Paz A., Izquierdo M., Redondo L.M., and Verrier A. Cephalic tetanus following minor facial abrasions: report of a case. J Oral Maxillofac Surg 59 7 (2001) 800-801
191. Jagoda A., Riggio S., and Burguieres T. Cephalic tetanus: a case report and review of the literature. Am J Emerg Med 6 (1988) 128-130 [Review] [26 refs]
192. Kara C.O., Cetin C.B., and Yalcin N. Cephalic tetanus as a result of rooster pecking: an unusual case. Scand J Infect Dis 34 1 (2002) 64-66
193. Vieira B.I., Dunne J.W., and Summers Q. Cephalic tetanus in an immunized patient. Clinical and electromyographic findings. Med J Aust 145 3-4 (1986) 156-157
194. Belman A.L. Tick-borne diseases. Semin Pediatr Neurol 6 4 (1999) 249-266
195. Duvillard C., and Romanet P. Acute otitis. Revue du Praticien 47 3 (1997) 335-340
196. Cheuk Y.L., Chow C.K., and Hui Y. Neurological sequelae of acute otitis media in a six-month-old baby-facial nerve palsy: a case report. Hong Kong Pract 24 8 (2002) 401-404
197. Haddad Jr. J. Treatment of acute otitis media and its complications. Otolaryngol Clin North Am 27 3 (1994) 431-441
198. Kouppari G., Zaphiropoulou A., Stamos G., Papakostas K., Tsirepa M., Deliyianni V., et al. Pneumococcal acute otitis media in children. Acta Microbiol Hellenica 42 6 (1997) 835-842
199. Nokso-Koivisto J., Hovi T., and Pitkaranta A. Viral upper respiratory tract infections in young children with emphasis on acute otitis media. Int J Pediatr Otorhinolaryngol 70 8 (2006) 1333-1342
200. Verhoeff M., Van Der Veen E.L., Rovers M.M., Sanders E.A.M., and Schilder A.G.M. Chronic suppurative otitis media: a review. Int J Pediatr Otorhinolaryngol 70 1 (2006) 1-12
201. Furuta Y., Ohtani F., Fukuda S., Inuyama Y., and Nagashima K. Reactivation of varicella-zoster virus in delayed facial palsy after dental treatment and oro-facial surgery. J Med Virol 62 1 (2000) 42-45
202. Gomez-Gosalvez F.A., Menor-Serrano F., Escriva-Tomas P., Clemente-Yago F., Sala-Sanchez A.G., Rubio-Soriano A., et al. Ischemic stroke secondary to post varicella angiopathy in a 3 year old male. Rev Neurol 36 10 (2003) 930-932 [in Spanish]
203. Hato N., Kisaki H., Honda N., Gyo K., Murakami S., and Yanagihara N. Ramsay Hunt syndrome in children. Ann Neurol 48 2 (2000) 254-256
204. Hyden D., and Roberg M. Diagnosis of Ramsey Hunt syndrome is both simple and difficult. The viral attack is more extensive than expected earlier. Lakartidningen 97 10 (2000) 1114-1120 [in Swedish]
205. Ikeda M., Hiroshige K., Abiko Y., and Onoda K. Impaired specific cellular immunity to the varicella-zoster virus in patients with herpes zoster oticus. J Laryngol Otol 110 10 (1996) 918-921
206. Ogino S. Recurrent facial paralysis-relation to varicella-zoster virus antibody levels and skin test. Otolaryngology 52 1 (1980) 47-50
207. Day T.A., Hornig J.D., Sharma A.K., Brescia F., Gillespie M.B., and Lathers D. Melanoma of the head and neck. Curr Treat Options Oncol 6 1 (2005) 19-30
208. Ginsberg L.E., and DeMonte F. Case 16: facial nerve schwannoma with middle cranial fossa involvement. Radiology 213 (1999) 364-368
209. Coppens T., Van Den Bergh P., Duprez T.J., Jeanjean A., De Ridder F., and Sindic C.J.M. Paraneoplastic rhombencephalitis and brachial plexopathy in two cases of amphiphysin auto-immunity. Eur Neurol 55 2 (2006) 80-83
210. Brinar V.V., Poser C.M., Basic S., and Petelin Z. Sudden onset aphasic hemiplegia: an unusual manifestation of disseminated encephalomyelitis. Clin Neurol Neurosurg 106 3 (2004) 187-196
211. Poon L.K., Lun K.S., and Ng Y.M. Facial nerve palsy and Kawasaki disease. Hong Kong Med J 6 2 (2000) 224-226
212. Biezeveld M.H., Voorbrood B.S., Clur S.A.B., and Kuijpers T.W. Facial nerve palsy in a thirteen-year-old male youth with Kawasaki disease. Pediatr Infect Dis J 21 5 (2002) 442-443
213. Buchner H., Ferbert A., and Hundgen R. Polyneuritis cranialis? Brain stem encephalitis and myelitis following preventive influenza vaccination. Nervenarzt 59 11 (1988) 679-682 [in German]
214. Hughes G.B., Barna B.P., Kinney S.E., Goren H., Sweeney P.J., Valenzuela R., et al. Immune reactivity in Bell's palsy. Otolaryngol Head Neck Surg 95 5 (1986) 586-588
215. Kisaki H., Hato N., Mizobuchi M., Honda N., Takahashi H., Wakisaka H., et al. Role of T-lymphocyte subsets in facial nerve paralysis owing to the reactivation of herpes simplex virus type 1. Acta Oto-Laryngol 125 3 (2005) 316-321
216. McGovern F.H., Estevez J., and Jackson R. Immunological concept for Bell's palsy: further experimental study. Ann Otol Rhinol Laryngol 86 3 Pt 1 (1977) 300-305
217. Ropper A.H. Further regional variants of acute immune polyneuropathy: Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 51 7 (1994) 671-675
218. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23 30 (2005) 3876-3886
219. Hughes P., Holt S., Rowell N.R., and Dodd J.K. Relationship of phytohaemagglutinin-induced lymphocyte transformation to disease activity in systemic lupus erythematosus. Ann Rheum Dis 35 2 (1976) 97-105
220. Ch'ien L.T., and Halsey Jr. J.H. Trigeminal sensory neuropathy and Bell's palsy. N Engl J Med 282 4 (1970) 224-225
221. Searl S.S. Minor trauma, disastrous results. Surv Opthalmol 31 (1987) 337-342
222. Glarner H., Meuli M., Hof E., Gallati V., Nadal D., Fisch U., et al. Management of petrous bone fractures in children: analysis of 127 cases. J Trauma 36 (1994) 198-201
223. Gray R.L. Peripheral facial nerve paralysis of dental origin. Br J Oral Surg 16 2 (1978) 143-150
224. Ndiokwelu E. Bell's palsy-a review of five cases seen at Unth Dental Clinic, Enugu Nigeria. Odontostomatol Trop 28 111 (2005) 34-36
225. Watanabe K., Hagura R., Akanuma Y., Takasu T., Kajinuma H., Kuzuya N., et al. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10 1 (1990) 19-27
226. Zaidi F.H., Gregory-Evans K., Acheson J.F., and Ferguson V. Familial Bell's palsy in females: a phenotype with a predilection for eyelids and lacrimal gland. Orbit 24 2 (2005) 121-124
227. Siol T., Huber M., and Buchner H. Posttraumatic Bell's palsy. Am J Psychiatry 158 (2001) 322
228. Russell J.W. Bell palsy. MedLink Neurology (2006). http://www.medlink.com/medlinkcontent.asp URL: http://www.medlink.com/medlinkcontent.asp, Access date: May 5, 2007
229. Kharoubi S. Peripheral facial paralysis associated with anti-tetanic serotherapy: a case report. Rev Neurol 161 4 (2005) 469-471 [in French]